City of Hope celebrates the passage of the Cancer Patients Bill of Rights by the California state legislature.
The Cancer Patients Bill of Rights establishes six principles to support the best cancer care for patients in California, such as being able to fully understand their diagnosis, being informed about treatment options in culturally appropriate and understandable language, timely access to cancer subspecialists, and timely access to clinical trials and innovative treatment options.
At City of Hope, we are proud to be a leader both in cancer care innovation and in advocating for access to potentially lifesaving care for patients. Thank you to Senator Susan Rubio for championing the Cancer Patients Bill of Rights resolution, and to our Cancer Care is Different coalition members for their partnership.
#####
About City of Hope
City of Hope is an independent biomedical research and treatment center for cancer, diabetes and other life-threatening diseases. Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope’s translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked among the nation’s “Best Hospitals” in cancer by U.S. News & World Report. Its main campus is located near Los Angeles, with additional locations throughout Southern California and in Arizona. Translational Genomics Research Institute (TGen) became a part of City of Hope in 2016. AccessHopeTM, a subsidiary launched in 2019, serves employers and their health care partners by providing access to NCI-designated cancer center expertise. For more information about City of Hope, follow us on Facebook, Twitter, YouTube or Instagram.